喘中多克索菲林的有效性和安全性概况:一个元分析
Fa Gao1, Jian Li1, Yulong Hou1
1College of Chinese Medicine, Changchun University of Chinese Medicine, Changchun, Jilin, China.
概括
多克索菲林在喘治疗中表现有前途,因为它显著减少了不良事件和喘恶化. 虽然它没有改善FEV1等肺功能指标,但它的安全性和减少的不良反应表明它对喘患者有潜在的长期益处.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 喘是一种慢性呼吸道疾病,影响全球数百万人.
- 目前的治疗方法旨在控制症状并预防恶化.
- 一种新型的丁衍生物多克索菲林 (doxofylline) 正在研究其在喘治疗中的治疗潜力.
研究的目的:
- 评估多克索菲林在喘管理中的有效性和安全性.
- 为了在随机对照试验 (RCT) 中比较多克索菲林与对照组的影响.
主要方法:
- 在2023年3月之前发表的RCT的系统审查和元分析.
- 研究来源来自EMBASE,科克伦图书馆,PubMed和科学网.
- 偏差风险工具 (RoB2) 评估了RCT质量;计算了相对风险 (RR) 和加权平均差异 (WMD).
主要成果:
- 分析了8项涉及1627名患者的试验.
- 没有观察到FEV1,使用阿尔布特罗尔,FVC或FEV1预测值的显著变化.
- 多克索菲林显著减少了不良反应 (RR=0.71) 和喘事件 (WMD=-0.18).
- 亚组分析表明,与其他喘药物结合使用时,疗效不同.
结论:
- 德克索菲林治疗显示,喘相关的不良事件和恶化显著减少.
- 该药物表现出有利的安全性,这表明长期喘管理可能有好处.
相关概念视频
Antiasthma Drugs: Methylxanthines
209
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
209
Antiasthma Drugs: Leukotriene Modifiers
253
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
253
Antiasthma Drugs: β2-Adrenoceptor Agonists
239
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
239
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
246
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
246
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
COPD: Management Using Bronchodilators and Corticosteroids
188
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
188


